-
Self-organized clustering, prediction, and superposition of long-term cognitive decline from short-term individual cognitive test scores in Alzheimer's disease
Authors:
Hiroyuki Sato,
Keisuke Suzuki,
Atsushi Hashizume,
Ryoichi Hanazawa,
Masanao Sasaki,
Akihiro Hirakawa,
the Japanese Alzheimer's Disease Neuroimaging Initiative,
the Alzheimer's Disease Neuroimaging Initiative
Abstract:
Progressive cognitive decline spanning across decades is characteristic of Alzheimer's disease (AD). Various predictive models have been designed to realize its early onset and study the long-term trajectories of cognitive test scores across populations of interest. Research efforts have been geared towards superimposing patients' cognitive test scores with the long-term trajectory denoting gradua…
▽ More
Progressive cognitive decline spanning across decades is characteristic of Alzheimer's disease (AD). Various predictive models have been designed to realize its early onset and study the long-term trajectories of cognitive test scores across populations of interest. Research efforts have been geared towards superimposing patients' cognitive test scores with the long-term trajectory denoting gradual cognitive decline, while considering the heterogeneity of AD. Multiple trajectories representing cognitive assessment for the long-term have been developed based on various parameters, highlighting the importance of classifying several groups based on disease progression patterns. In this study, a novel method capable of self-organized prediction, classification, and the overlay of long-term cognitive trajectories based on short-term individual data was developed, based on statistical and differential equation modeling. We validated the predictive accuracy of the proposed method for the long-term trajectory of cognitive test score results on two cohorts: the Alzheimer's Disease Neuroimaging Initiative (ADNI) study and the Japanese ADNI study. We also presented two practical illustrations of the simultaneous evaluation of risk factor associated with both the onset and the longitudinal progression of AD, and an innovative randomized controlled trial design for AD that standardizes the heterogeneity of patients enrolled in a clinical trial. These resources would improve the power of statistical hypothesis testing and help evaluate the therapeutic effect. The application of predicting the trajectory of longitudinal disease progression goes beyond AD, and is especially relevant for progressive and neurodegenerative disorders.
△ Less
Submitted 19 February, 2024;
originally announced February 2024.
-
A Weighted Prognostic Covariate Adjustment Method for Efficient and Powerful Treatment Effect Inferences in Randomized Controlled Trials
Authors:
Alyssa M. Vanderbeek,
Anna A. Vidovszky,
Jessica L. Ross,
Arman Sabbaghi,
Jonathan R. Walsh,
Charles K. Fisher,
the Critical Path for Alzheimer's Disease,
the Alzheimer's Disease Neuroimaging Initiative,
the European Prevention of Alzheimer's Disease,
Consortium,
the Alzheimer's Disease Cooperative Study
Abstract:
A crucial task for a randomized controlled trial (RCT) is to specify a statistical method that can yield an efficient estimator and powerful test for the treatment effect. A novel and effective strategy to obtain efficient and powerful treatment effect inferences is to incorporate predictions from generative artificial intelligence (AI) algorithms into covariate adjustment for the regression analy…
▽ More
A crucial task for a randomized controlled trial (RCT) is to specify a statistical method that can yield an efficient estimator and powerful test for the treatment effect. A novel and effective strategy to obtain efficient and powerful treatment effect inferences is to incorporate predictions from generative artificial intelligence (AI) algorithms into covariate adjustment for the regression analysis of a RCT. Training a generative AI algorithm on historical control data enables one to construct a digital twin generator (DTG) for RCT participants, which utilizes a participant's baseline covariates to generate a probability distribution for their potential control outcome. Summaries of the probability distribution from the DTG are highly predictive of the trial outcome, and adjusting for these features via regression can thus improve the quality of treatment effect inferences, while satisfying regulatory guidelines on statistical analyses, for a RCT. However, a critical assumption in this strategy is homoskedasticity, or constant variance of the outcome conditional on the covariates. In the case of heteroskedasticity, existing covariate adjustment methods yield inefficient estimators and underpowered tests. We propose to address heteroskedasticity via a weighted prognostic covariate adjustment methodology (Weighted PROCOVA) that adjusts for both the mean and variance of the regression model using information obtained from the DTG. We prove that our method yields unbiased treatment effect estimators, and demonstrate via comprehensive simulation studies and case studies from Alzheimer's disease that it can reduce the variance of the treatment effect estimator, maintain the Type I error rate, and increase the power of the test for the treatment effect from 80% to 85%~90% when the variances from the DTG can explain 5%~10% of the variation in the RCT participants' outcomes.
△ Less
Submitted 25 September, 2023;
originally announced September 2023.
-
Bayesian inference and role of astrocytes in amyloid-beta dynamics with modelling of Alzheimer's disease using clinical data
Authors:
Hina Shaheen,
Roderick Melnik,
The Alzheimer's Disease Neuroimaging Initiative
Abstract:
Alzheimer's disease (AD) is a prominent, worldwide, age-related neurodegenerative disease that currently has no systemic treatment. Strong evidence suggests that permeable amyloid-beta peptide (Abeta) oligomers, astrogliosis and reactive astrocytosis cause neuronal damage in AD. A large amount of Abeta is secreted by astrocytes, which contributes to the total Abeta deposition in the brain. This su…
▽ More
Alzheimer's disease (AD) is a prominent, worldwide, age-related neurodegenerative disease that currently has no systemic treatment. Strong evidence suggests that permeable amyloid-beta peptide (Abeta) oligomers, astrogliosis and reactive astrocytosis cause neuronal damage in AD. A large amount of Abeta is secreted by astrocytes, which contributes to the total Abeta deposition in the brain. This suggests that astrocytes may also play a role in AD, leading to increased attention to their dynamics and associated mechanisms. Therefore, in the present study, we developed and evaluated novel stochastic models for Abeta growth using ADNI data to predict the effect of astrocytes on AD progression in a clinical trial. In the AD case, accurate prediction is required for a successful clinical treatment plan. Given that AD studies are observational in nature and involve routine patient visits, stochastic models provide a suitable framework for modelling AD. Using the approximate Bayesian computation (ABC) approach, the AD etiology may be modelled as a multi-state disease process. As a result, we use this approach to examine the weak and strong influence of astrocytes at multiple disease progression stages using ADNI data from the baseline to 2-year visits for AD patients whose ages ranged from 50 to 90 years. Based on ADNI data, we discovered that the strong astrocyte effect (i.e., a higher concentration of astrocytes as compared to Abeta) could help to lower or clear the growth of Abeta, which is a key to slowing down AD progression.
△ Less
Submitted 21 June, 2023;
originally announced June 2023.
-
Transferring Models Trained on Natural Images to 3D MRI via Position Encoded Slice Models
Authors:
Umang Gupta,
Tamoghna Chattopadhyay,
Nikhil Dhinagar,
Paul M. Thompson,
Greg Ver Steeg,
The Alzheimer's Disease Neuroimaging Initiative
Abstract:
Transfer learning has remarkably improved computer vision. These advances also promise improvements in neuroimaging, where training set sizes are often small. However, various difficulties arise in directly applying models pretrained on natural images to radiologic images, such as MRIs. In particular, a mismatch in the input space (2D images vs. 3D MRIs) restricts the direct transfer of models, of…
▽ More
Transfer learning has remarkably improved computer vision. These advances also promise improvements in neuroimaging, where training set sizes are often small. However, various difficulties arise in directly applying models pretrained on natural images to radiologic images, such as MRIs. In particular, a mismatch in the input space (2D images vs. 3D MRIs) restricts the direct transfer of models, often forcing us to consider only a few MRI slices as input. To this end, we leverage the 2D-Slice-CNN architecture of Gupta et al. (2021), which embeds all the MRI slices with 2D encoders (neural networks that take 2D image input) and combines them via permutation-invariant layers. With the insight that the pretrained model can serve as the 2D encoder, we initialize the 2D encoder with ImageNet pretrained weights that outperform those initialized and trained from scratch on two neuroimaging tasks -- brain age prediction on the UK Biobank dataset and Alzheimer's disease detection on the ADNI dataset. Further, we improve the modeling capabilities of 2D-Slice models by incorporating spatial information through position embeddings, which can improve the performance in some cases.
△ Less
Submitted 2 March, 2023;
originally announced March 2023.
-
Predicting Time-to-conversion for Dementia of Alzheimer's Type using Multi-modal Deep Survival Analysis
Authors:
Ghazal Mirabnahrazam,
Da Ma,
Cédric Beaulac,
Sieun Lee,
Karteek Popuri,
Hyunwoo Lee,
Jiguo Cao,
James E Galvin,
Lei Wang,
Mirza Faisal Beg,
the Alzheimer's Disease Neuroimaging Initiative
Abstract:
Dementia of Alzheimer's Type (DAT) is a complex disorder influenced by numerous factors, but it is unclear how each factor contributes to disease progression. An in-depth examination of these factors may yield an accurate estimate of time-to-conversion to DAT for patients at various disease stages. We used 401 subjects with 63 features from MRI, genetic, and CDC (Cognitive tests, Demographic, and…
▽ More
Dementia of Alzheimer's Type (DAT) is a complex disorder influenced by numerous factors, but it is unclear how each factor contributes to disease progression. An in-depth examination of these factors may yield an accurate estimate of time-to-conversion to DAT for patients at various disease stages. We used 401 subjects with 63 features from MRI, genetic, and CDC (Cognitive tests, Demographic, and CSF) data modalities in the Alzheimer's Disease Neuroimaging Initiative (ADNI) database. We used a deep learning-based survival analysis model that extends the classic Cox regression model to predict time-to-conversion to DAT. Our findings showed that genetic features contributed the least to survival analysis, while CDC features contributed the most. Combining MRI and genetic features improved survival prediction over using either modality alone, but adding CDC to any combination of features only worked as well as using only CDC features. Consequently, our study demonstrated that using the current clinical procedure, which includes gathering cognitive test results, can outperform survival analysis results produced using costly genetic or CSF data.
△ Less
Submitted 2 May, 2022;
originally announced May 2022.
-
MRI-based Multi-task Decoupling Learning for Alzheimer's Disease Detection and MMSE Score Prediction: A Multi-site Validation
Authors:
Xu Tian,
** Liu,
Hulin Kuang,
Yu Sheng,
Jianxin Wang,
The Alzheimer's Disease Neuroimaging Initiative
Abstract:
Accurately detecting Alzheimer's disease (AD) and predicting mini-mental state examination (MMSE) score are important tasks in elderly health by magnetic resonance imaging (MRI). Most of the previous methods on these two tasks are based on single-task learning and rarely consider the correlation between them. Since the MMSE score, which is an important basis for AD diagnosis, can also reflect the…
▽ More
Accurately detecting Alzheimer's disease (AD) and predicting mini-mental state examination (MMSE) score are important tasks in elderly health by magnetic resonance imaging (MRI). Most of the previous methods on these two tasks are based on single-task learning and rarely consider the correlation between them. Since the MMSE score, which is an important basis for AD diagnosis, can also reflect the progress of cognitive impairment, some studies have begun to apply multi-task learning methods to these two tasks. However, how to exploit feature correlation remains a challenging problem for these methods. To comprehensively address this challenge, we propose a MRI-based multi-task decoupled learning method for AD detection and MMSE score prediction. First, a multi-task learning network is proposed to implement AD detection and MMSE score prediction, which exploits feature correlation by adding three multi-task interaction layers between the backbones of the two tasks. Each multi-task interaction layer contains two feature decoupling modules and one feature interaction module. Furthermore, to enhance the generalization between tasks of the features selected by the feature decoupling module, we propose the feature consistency loss constrained feature decoupling module. Finally, in order to exploit the specific distribution information of MMSE score in different groups, a distribution loss is proposed to further enhance the model performance. We evaluate our proposed method on multi-site datasets. Experimental results show that our proposed multi-task decoupled representation learning method achieves good performance, outperforming single-task learning and other existing state-of-the-art methods.
△ Less
Submitted 7 July, 2023; v1 submitted 2 April, 2022;
originally announced April 2022.
-
Machine Learning Based Multimodal Neuroimaging Genomics Dementia Score for Predicting Future Conversion to Alzheimer's Disease
Authors:
Ghazal Mirabnahrazam,
Da Ma,
Sieun Lee,
Karteek Popuri,
Hyunwoo Lee,
Jiguo Cao,
Lei Wang,
James E Galvin,
Mirza Faisal Beg,
the Alzheimer's Disease Neuroimaging Initiative
Abstract:
Background: The increasing availability of databases containing both magnetic resonance imaging (MRI) and genetic data allows researchers to utilize multimodal data to better understand the characteristics of dementia of Alzheimer's type (DAT). Objective: The goal of this study was to develop and analyze novel biomarkers that can help predict the development and progression of DAT. Methods: We use…
▽ More
Background: The increasing availability of databases containing both magnetic resonance imaging (MRI) and genetic data allows researchers to utilize multimodal data to better understand the characteristics of dementia of Alzheimer's type (DAT). Objective: The goal of this study was to develop and analyze novel biomarkers that can help predict the development and progression of DAT. Methods: We used feature selection and ensemble learning classifier to develop an image/genotype-based DAT score that represents a subject's likelihood of develo** DAT in the future. Three feature types were used: MRI only, genetic only, and combined multimodal data. We used a novel data stratification method to better represent different stages of DAT. Using a pre-defined 0.5 threshold on DAT scores, we predicted whether or not a subject would develop DAT in the future. Results: Our results on Alzheimer's Disease Neuroimaging Initiative (ADNI) database showed that dementia scores using genetic data could better predict future DAT progression for currently normal control subjects (Accuracy=0.857) compared to MRI (Accuracy=0.143), while MRI can better characterize subjects with stable mild cognitive impairment (Accuracy=0.614) compared to genetics (Accuracy=0.356). Combining MRI and genetic data showed improved classification performance in the remaining stratified groups. Conclusion: MRI and genetic data can contribute to DAT prediction in different ways. MRI data reflects anatomical changes in the brain, while genetic data can detect the risk of DAT progression prior to the symptomatic onset. Combining information from multimodal data in the right way can improve prediction performance.
△ Less
Submitted 10 March, 2022;
originally announced March 2022.
-
Diagnosis of Alzheimer's Disease via Multi-modality 3D Convolutional Neural Network
Authors:
Yechong Huang,
Jiahang Xu,
Yuncheng Zhou,
Tong Tong,
Xiahai Zhuang,
the Alzheimer's Disease Neuroimaging Initiative
Abstract:
Alzheimer's Disease (AD) is one of the most concerned neurodegenerative diseases. In the last decade, studies on AD diagnosis attached great significance to artificial intelligence (AI)-based diagnostic algorithms. Among the diverse modality imaging data, T1-weighted MRI and 18F-FDGPET are widely researched for this task. In this paper, we propose a novel convolutional neural network (CNN) to fuse…
▽ More
Alzheimer's Disease (AD) is one of the most concerned neurodegenerative diseases. In the last decade, studies on AD diagnosis attached great significance to artificial intelligence (AI)-based diagnostic algorithms. Among the diverse modality imaging data, T1-weighted MRI and 18F-FDGPET are widely researched for this task. In this paper, we propose a novel convolutional neural network (CNN) to fuse the multi-modality information including T1-MRI and FDG-PDT images around the hippocampal area for the diagnosis of AD. Different from the traditional machine learning algorithms, this method does not require manually extracted features, and utilizes the stateof-art 3D image-processing CNNs to learn features for the diagnosis and prognosis of AD. To validate the performance of the proposed network, we trained the classifier with paired T1-MRI and FDG-PET images using the ADNI datasets, including 731 Normal (NL) subjects, 647 AD subjects, 441 stable MCI (sMCI) subjects and 326 progressive MCI (pMCI) subjects. We obtained the maximal accuracies of 90.10% for NL/AD task, 87.46% for NL/pMCI task, and 76.90% for sMCI/pMCI task. The proposed framework yields comparative results against state-of-the-art approaches. Moreover, the experimental results have demonstrated that (1) segmentation is not a prerequisite by using CNN, (2) the hippocampal area provides enough information to give a reference to AD diagnosis. Keywords: Alzheimer's Disease, Multi-modality, Image Classification, CNN, Deep Learning, Hippocampal
△ Less
Submitted 26 February, 2019;
originally announced February 2019.
-
Neuroimaging Modality Fusion in Alzheimer's Classification Using Convolutional Neural Networks
Authors:
Arjun Punjabi,
Adam Martersteck,
Yanran Wang,
Todd B. Parrish,
Aggelos K. Katsaggelos,
the Alzheimer's Disease Neuroimaging Initiative
Abstract:
Automated methods for Alzheimer's disease (AD) classification have the potential for great clinical benefits and may provide insight for combating the disease. Machine learning, and more specifically deep neural networks, have been shown to have great efficacy in this domain. These algorithms often use neurological imaging data such as MRI and PET, but a comprehensive and balanced comparison of th…
▽ More
Automated methods for Alzheimer's disease (AD) classification have the potential for great clinical benefits and may provide insight for combating the disease. Machine learning, and more specifically deep neural networks, have been shown to have great efficacy in this domain. These algorithms often use neurological imaging data such as MRI and PET, but a comprehensive and balanced comparison of these modalities has not been performed. In order to accurately determine the relative strength of each imaging variant, this work performs a comparison study in the context of Alzheimer's dementia classification using the Alzheimer's Disease Neuroimaging Initiative (ADNI) dataset. Furthermore, this work analyzes the benefits of using both modalities in a fusion setting and discusses how these data types may be leveraged in future AD studies using deep learning.
△ Less
Submitted 12 November, 2018;
originally announced November 2018.
-
Development and validation of a novel dementia of Alzheimer's type (DAT) score based on metabolism FDG-PET imaging
Authors:
Karteek Popuri,
Rakesh Balachandar,
Kathryn Alpert,
Donghuan Lu,
Mahadev Bhalla,
Ian Mackenzie,
Robin Ging-Yuek Hsiung,
Lei Wang,
Mirza Faisal Beg,
the Alzhemier's Disease Neuroimaging Initiative
Abstract:
Fluorodeoxyglucose positron emission tomography (FDG-PET) imaging based 3D topographic brain glucose metabolism patterns from normal controls (NC) and individuals with dementia of Alzheimer's type (DAT) are used to train a novel multi-scale ensemble classification model. This ensemble model outputs a FDG-PET DAT score (FPDS) between 0 and 1 denoting the probability of a subject to be clinically di…
▽ More
Fluorodeoxyglucose positron emission tomography (FDG-PET) imaging based 3D topographic brain glucose metabolism patterns from normal controls (NC) and individuals with dementia of Alzheimer's type (DAT) are used to train a novel multi-scale ensemble classification model. This ensemble model outputs a FDG-PET DAT score (FPDS) between 0 and 1 denoting the probability of a subject to be clinically diagnosed with DAT based on their metabolism profile. A novel 7 group image stratification scheme is devised that groups images not only based on their associated clinical diagnosis but also on past and future trajectories of the clinical diagnoses, yielding a more continuous representation of the different stages of DAT spectrum that mimics a real-world clinical setting. The potential for using FPDS as a DAT biomarker was validated on a large number of FDG-PET images (N=2984) obtained from the Alzheimer's Disease Neuroimaging Initiative (ADNI) database taken across the proposed stratification, and a good classification AUC (area under the curve) of 0.78 was achieved in distinguishing between images belonging to subjects on a DAT trajectory and those images taken from subjects not progressing to a DAT diagnosis. Further, the FPDS biomarker achieved state-of-the-art performance on the mild cognitive impairment (MCI) to DAT conversion prediction task with an AUC of 0.81, 0.80, 0.77 for the 2, 3, 5 years to conversion windows respectively.
△ Less
Submitted 2 November, 2017;
originally announced November 2017.
-
Scalable Bayesian regression in high dimensions with multiple data sources
Authors:
Konstantinos Perrakis,
Sach Mukherjee,
the Alzheimers Disease Neuroimaging Initiative
Abstract:
Applications of high-dimensional regression often involve multiple sources or types of covariates. We propose methodology for this setting, emphasizing the "wide data" regime with large total dimensionality p and sample size n<<p. We focus on a flexible ridge-type prior with shrinkage levels that are specific to each data type or source and that are set automatically by empirical Bayes. All estima…
▽ More
Applications of high-dimensional regression often involve multiple sources or types of covariates. We propose methodology for this setting, emphasizing the "wide data" regime with large total dimensionality p and sample size n<<p. We focus on a flexible ridge-type prior with shrinkage levels that are specific to each data type or source and that are set automatically by empirical Bayes. All estimation, including setting of shrinkage levels, is formulated mainly in terms of inner product matrices of size n x n. This renders computation efficient in the wide data regime and allows scaling to problems with millions of features. Furthermore, the proposed procedures are free of user-set tuning parameters. We show how sparsity can be achieved by post-processing of the Bayesian output via constrained minimization of a certain Kullback-Leibler divergence. This yields sparse solutions with adaptive, source-specific shrinkage, including a closed-form variant that scales to very large p. We present empirical results from a simulation study based on real data and a case study in Alzheimer's disease involving millions of features and multiple data sources.
△ Less
Submitted 21 August, 2019; v1 submitted 2 October, 2017;
originally announced October 2017.
-
High-dimensional regression over disease subgroups
Authors:
Frank Dondelinger,
Sach Mukherjee,
The Alzheimer's Disease Neuroimaging Initiative
Abstract:
We consider high-dimensional regression over subgroups of observations. Our work is motivated by biomedical problems, where disease subtypes, for example, may differ with respect to underlying regression models, but sample sizes at the subgroup-level may be limited. We focus on the case in which subgroup-specific models may be expected to be similar but not necessarily identical. Our approach is t…
▽ More
We consider high-dimensional regression over subgroups of observations. Our work is motivated by biomedical problems, where disease subtypes, for example, may differ with respect to underlying regression models, but sample sizes at the subgroup-level may be limited. We focus on the case in which subgroup-specific models may be expected to be similar but not necessarily identical. Our approach is to treat subgroups as related problem instances and jointly estimate subgroup-specific regression coefficients. This is done in a penalized framework, combining an $\ell_1$ term with an additional term that penalizes differences between subgroup-specific coefficients. This gives solutions that are globally sparse but that allow information-sharing between the subgroups. We present algorithms for estimation and empirical results on simulated data and using Alzheimer's disease, amyotrophic lateral sclerosis and cancer datasets. These examples demonstrate the gains our approach can offer in terms of prediction and the ability to estimate subgroup-specific sparsity patterns.
△ Less
Submitted 9 December, 2016; v1 submitted 3 November, 2016;
originally announced November 2016.
-
Tensor Generalized Estimating Equations for Longitudinal Imaging Analysis
Authors:
Xiang Zhang,
Lexin Li,
Hua Zhou,
Dinggang Shen,
the Alzheimer's Disease Neuroimaging Initiative
Abstract:
In an increasing number of neuroimaging studies, brain images, which are in the form of multidimensional arrays (tensors), have been collected on multiple subjects at multiple time points. Of scientific interest is to analyze such massive and complex longitudinal images to diagnose neurodegenerative disorders and to identify disease relevant brain regions. In this article, we treat those problems…
▽ More
In an increasing number of neuroimaging studies, brain images, which are in the form of multidimensional arrays (tensors), have been collected on multiple subjects at multiple time points. Of scientific interest is to analyze such massive and complex longitudinal images to diagnose neurodegenerative disorders and to identify disease relevant brain regions. In this article, we treat those problems in a unifying regression framework with image predictors, and propose tensor generalized estimating equations (GEE) for longitudinal imaging analysis. The GEE approach takes into account intra-subject correlation of responses, whereas a low rank tensor decomposition of the coefficient array enables effective estimation and prediction with limited sample size. We propose an efficient estimation algorithm, study the asymptotics in both fixed $p$ and diverging $p$ regimes, and also investigate tensor GEE with regularization that is particularly useful for region selection. The efficacy of the proposed tensor GEE is demonstrated on both simulated data and a real data set from the Alzheimer's Disease Neuroimaging Initiative (ADNI).
△ Less
Submitted 19 December, 2014;
originally announced December 2014.
-
Fiber Direction Estimation, Smoothing and Tracking in Diffusion MRI
Authors:
Raymond K. W. Wong,
Thomas C. M. Lee,
Debashis Paul,
Jie Peng,
the Alzheimer's Disease Neuroimaging Initiative
Abstract:
Diffusion magnetic resonance imaging is an imaging technology designed to probe anatomical architectures of biological samples in an in vivo and non-invasive manner through measuring water diffusion. The contribution of this paper is threefold. First it proposes a new method to identify and estimate multiple diffusion directions within a voxel through a new and identifiable parametrization of the…
▽ More
Diffusion magnetic resonance imaging is an imaging technology designed to probe anatomical architectures of biological samples in an in vivo and non-invasive manner through measuring water diffusion. The contribution of this paper is threefold. First it proposes a new method to identify and estimate multiple diffusion directions within a voxel through a new and identifiable parametrization of the widely used multi-tensor model. Unlike many existing methods, this method focuses on the estimation of diffusion directions rather than the diffusion tensors. Second, this paper proposes a novel direction smoothing method which greatly improves direction estimation in regions with crossing fibers. This smoothing method is shown to have excellent theoretical and empirical properties. Lastly, this paper develops a fiber tracking algorithm that can handle multiple directions within a voxel. The overall methodology is illustrated with simulated data and a data set collected for the study of Alzheimer's disease by the Alzheimer's Disease Neuroimaging Initiative (ADNI).
△ Less
Submitted 24 September, 2015; v1 submitted 3 June, 2014;
originally announced June 2014.
-
Multiple Comparison Procedures for Neuroimaging Genomewide Association Studies
Authors:
Wen-Yu Hua,
Thomas E. Nichols,
Debashis Ghosh,
the Alzheimer's Disease Neuroimaging Initiative
Abstract:
Recent research in neuroimaging has focused on assessing associations between genetic variants that are measured on a genomewide scale and brain imaging phenotypes. A large number of works in the area apply massively univariate analyses on a genomewide basis to find single nucleotide polymorphisms that influence brain structure. In this paper, we propose using various dimensionality reduction meth…
▽ More
Recent research in neuroimaging has focused on assessing associations between genetic variants that are measured on a genomewide scale and brain imaging phenotypes. A large number of works in the area apply massively univariate analyses on a genomewide basis to find single nucleotide polymorphisms that influence brain structure. In this paper, we propose using various dimensionality reduction methods on both brain structural MRI scans and genomic data, motivated by the Alzheimer's Disease Neuroimaging Initiative (ADNI) study. We also consider a new multiple testing adjustment method and compare it with two existing false discovery rate (FDR) adjustment methods. The simulation results suggest an increase in power for the proposed method. The real data analysis suggests that the proposed procedure is able to find associations between genetic variants and brain volume differences that offer potentially new biological insights.
△ Less
Submitted 22 March, 2014; v1 submitted 11 February, 2014;
originally announced February 2014.
